Results 111 to 120 of about 68,309 (262)

To VAE or not to VAE: outcomes of radial scars/complex sclerosing lesions and papillary lesions without atypia in the King's College Hospital breast service (2017–2023)

open access: yesHistopathology, Volume 88, Issue 3, Page 583-590, February 2026.
Radial scars/complex sclerosing lesions (RS/CSL) without atypia have a low upgrade rate (1%) and could possibly be monitored radiologically, thus avoiding excision. Papillary lesions without atypia have a higher upgrade rate (4%) and should continue to undergo vacuum excision until we better understand these heterogeneous lesions.
Amy Llewellyn   +3 more
wiley   +1 more source

Bee products as alternatives in the treatment of viral infections

open access: yesJournal of the Science of Food and Agriculture, Volume 106, Issue 1, Page 33-54, 15 January 2026.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba   +3 more
wiley   +1 more source

European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions

open access: yesMolecular Oncology, Volume 20, Issue 1, Page 96-116, January 2026.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations related to cancer‐causing infections, namely H. pylori, HPV, HBV, HCV and HIV, positioned as recommendation number 12.
Catharina Johanna Alberts   +18 more
wiley   +1 more source

Using systems thinking to guide the dissemination of the European code against cancer, 5th edition

open access: yesMolecular Oncology, Volume 20, Issue 1, Page 170-187, January 2026.
Knowledge mobilisation is vital for cancer prevention. Using systems thinking, three substudies engaged stakeholders to identify effective strategies to disseminate the European Code Against Cancer, 5th edition (ECAC5). Stakeholders mapped barriers and facilitators and proposed actions focused on collaboration, accessible communication channels and ...
Erica D'Souza   +4 more
wiley   +1 more source

Coexistence of squamous cell tracheal papilloma and carcinoma treated with chemotherapy and radiotherapy: a case report

open access: yesTherapeutics and Clinical Risk Management, 2015
Dimitrios Paliouras,1 Apostolos Gogakos,1 Thomas Rallis,1 Fotios Chatzinikolaou,2 Christos Asteriou,1 Georgios Tagarakis,3 John Organtzis,4 Kosmas Tsakiridis,5 Drosos Tsavlis,4 Athanasios Zissimopoulos,6 Ioannis Kioumis,4 Wolfgang Hohenforst-Schmidt,7 ...
Paliouras D   +14 more
doaj  

European Code Against Cancer, 5th edition – organised cancer screening programmes

open access: yesMolecular Oncology, Volume 20, Issue 1, Page 134-153, January 2026.
ECAC5 updates cancer prevention recommendations on cancer screening. Individuals are recommended to take part in organised screening programmes for colorectal, breast, cervical and lung cancer, as recommended in their country. Policymakers should aim to implement sustainable, organised screening programmes for these cancer types to facilitate their ...
Esther Toes‐Zoutendijk   +19 more
wiley   +1 more source

Discrimination of benign and malignant non‐mass breast lesions using ultrasound radiomics with machine learning models

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Aims This study aims to enhance the preoperative diagnosis of non‐mass breast lesions (NMLs) by validating radiomics‐based machine learning models and assessing their performance alone and in combination with clinical ultrasound features to distinguish benign from malignant lesions.
Chunming Shi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy